Back to the Top
Dear all,
What are your experiences with the bioanalytical method
radioimmunoassay (as a competitive method).
At least four of every six QC samples in one analytical run should be
within 15 % of their respective nominal value (FDA guidance for
industry).
The rule is valid for HPLC and LC-MS/MS methods.
Is it acceptable to increase the limit on 20 % for the RIA due to the
higher scattering of the measured RIA results?
Dorothee Krone
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)